2. VASCULITIS: Talk Outline
• Introduction and Definitions
• Approach to vasculitis
• Specific Disorders:
– Giant Cell Arteritis
– Granulomatous polyangiitis (Wegener’s)
– Microscopic Polyangiitis
– Polyarteritis Nodosa
• Take Home
3. VASCULITIS: principles 1
• Vasculitis- Inflammation of blood vessels
characterised by leucocytic infiltration of the
vessel walls
• Different patterns of vessels’ involvement
in different entities
• Vessel lumen compromised ischemia of the
corresponding organ
5. VASCULITIS: principles 2
systemic diseases that can affect many different organ systems
For example, involvement of
•glomerular capillaries causes nephritis;
•alveolar capillaries, pulmonary hemorrhage;
•dermal venules, purpura;
•upper respiratory tract mucosal venules, rhinitis and sinusitis;
•abdominal visceral arteries, abdominal pain; and
•epineural arteries, mononeuritis multiplex.
can be difficult to diagnose: challenging clinical
picture even for experienced clinicians..
can be life-threatening
6. Small-Vessel Vasculitis is necrotizing vasculitis that predominantly affects
vessels including capillaries, venules, and arterioles; however, arteries, especially
small arteries, also may be involved.The most common renal target for small-vessel
vasculitis is glomerular capillaries.
Medium-Vessel Vasculitis is necrotizing arteritis that predominantly affects
major visceral arteries. In the kidneys, the interlobar arteries and arcuate arteries
are affected most frequently, although any arteries from the main renal artery to the
smallest interlobular arteries may be affected.
Large-Vessel Vasculitis is chronic granulomatous arteritis that predominantly
affects the aorta and its major branches more often than other forms of
vasculitis.When there is renal involvement, the ostia of the renal arteries and the main
renal arteries are most often affected. The most common clinical renal manifestation is
renovascular hypertension.
7.
8. Pathology
The acute vascular lesion of the pauci-immune small-vessel vasculitides is segmental fibrinoid
necrosis, often accompanied by leukocyte infiltration and leukocytoclasia (leukocyte
fragmentation).
The earliest vasculitic lesions have infiltrating neutrophils that are quickly replaced by
predominantly mononuclear leukocytes.
The acute necrotizing lesions evolve into sclerotic lesions and may be complicated by
thrombosis
Necrotizing arteritis of interlobular artery in
patient
with ANCA-associated small-vessel vasculitis.
There is segmental
fibrinoid necrosis with adjacent perivascular
leukocyte infiltration
9. Pathology …
Early mild lesions have segmental fibrinoid necrosis with or
without an adjacent small crescent.
Non-necrotic segments within segmentally injured glomeruli) and
glomeruli without necrosis typically have slight or no histologic
abnormalities.
Segmental glomerular necrosis and
crescent formation
in patient with ANCA-associated small-
vessel vasculitis. The
fibrinoid material is red.
The uninvolved segments appear normal.
10. Pathology……Severe acute lesions may
have essentially global necrosis with
large circumferential crescents
Global glomerular necrosis and
circumferential crescent
formation in a glomerulus from patient
with ANCA-associated small-vessel
vasculitis.
11. Pathology……In addition to GN, patients with AAV also may
have renal arteritis, most often affecting interlobular arteries
and medullary angiitis affecting the vasa recta.
The medullary angiitis may be severe enough to cause papillary
necrosis, although this is a rare complication.
Medullary leukocytoclastic angiitis
involving vasa recta in a patient with
granulomatosis with polyangiitis
12.
13. Histopathologic classification for AAV GN
Sclerotic class (50% globally sclerotic glomeruli),
Focal class (50% normal glomeruli),
Crescentic class (50% of glomeruli with cellular crescents),
Mixed class if none of these features predominated.
Renal survival at 5 years was
93% for the focal class,
76% for crescentic class,
61% for mixed class, and
50% for sclerotic class.
Validation studies are
underway to better understand
the utility of this classification.
14. When should vasculitis be suspected?
• MULTISYSTEM inflammatory disease
• Significant CONSTITUTIONAL SYMPTOMS
• RAPIDLY PROGRESSIVE organ dysfunction
• HIGH ESR
SEVERE anemia
PLATELETS > 500K
15. When should vasculitis be suspected?
CLINICAL FEATURES PARTICULARLY
SUGGESTIVE of small vessel inflammation:
•SKIN: palpable purpura *
•LUNGS: pulmonary infiltrates /
hemoptysis
•KIDNEY: active urinary sediment
•NEURO: foot drop **
16. HISTORY: PATIENT’S STORY
Neither sensitive nor specific for the diagnosis of vasculitis such as fever, fatigue,
weight loss, and arthralgias
A history of eye inflammation, particularly scleritis.
Persistent nasal crusting, epistaxis, or other upper airway disease.
The presence of acute foot drop or wrist drop may be due to a motor neuropathy
from an ischemic process.
Limb claudication, especially in the upper extremities or in a person at low risk for
atherosclerosis, is suggestive of a large arterial occlusion from Takayasu arteritis or
giant cell arteritis (GCA).
Unexplained hemoptysis raises concern for alveolar hemorrhage and AAV.
The combination of lung hemorrhage and renal insufficiency should immediately
raise concern for vasculitis
17. PHYSICAL EXAM: BODY’S STORY
Findings of a sensory and/or motor neuropathy ..classical mononeuritis
multiplex and peripheral symmetric or asymmetric polyneuropathy.
Palpable purpura –is a strong sign of cutaneous leukocytoclastic vasculitis
Absent, diminished, or tender pulses, bruits, or blood pressure
discrepancies.
A careful and full vascular examination is extremely helpful in identifying
signs of large-vessel vasculitis .
The vascular examination should include palpation for pulses in multiple
areas including, but not limited to, the radial, brachial, carotid, femoral,
popliteal, posterior tibial, and dorsalis pedis arteries.
Auscultation for bruits in the regions of the carotid, subclavian, renal, and
femoral arteries and the thoracic and abdominal aorta.
35. MUSCULOSKELETAL
• Polyarthralgias - common
• Polyarthritis - less common
• Myalgias - common
• Myositis - biopsy may demonstrate
vasculitis in muscle
40. Questions?
• In the ACR diagnostic criteria for Giant Cell
Arteritis (Temporal Arteritis), a patient needs
to be greater than what age?
A. > 40 years
B. > 50 years
C. > 60 years
D. > 70 years
E. > 80 years
41. Questions?
• In the ACR diagnostic criteria for Giant Cell
Arteritis (Temporal Arteritis), a patient needs
to be greater than what age?
A. > 40 years
B. > 50 years
C. > 60 years
D. > 70 years
E. > 80 years
-Almost all are > 60
-Average age is 70
42. Giant Cell Arteritis
ACR Criteria (3 of 5)
• Age > 50
• New onset headache
• ESR (Westergren) ≥ 50
• Abnormal artery biopsy
(mononuclear cell infiltrate, granulomatous
inflammation, usually multinucleated giant cells)
• Temporal artery
abnormality (tender or decreased pulse)
Arthritis Rheum. 1990;33:1122.
44. GCA:Biopsy
• Temporal artery biopsy
– large specimen (4-6 cm)
– multiple sections evaluated
• Infiltration of vessel wall with
WBC
• Granulomata, Giant Cells
• Necrotic material
45. GCA: Therapy
• Corticosteroids mainstay of therapy
(~1 mg/kg)
– Calcium and vitamin D
– Consider bisphosphonates
• Try to prevent visual loss with therapy:
– Treat, then biopsy!
47. Questions?
• The confirmatory antibody for a positive C-
ANCA in a patient suspected of having
Wegener’s Granulomatosus is:
A. Topoisomerase
B. Histidine tRNA synthetase
C. Smith
D. Proteinase-3
E. Myeloperoxidase
48. Questions?
• The confirmatory antigen for a positive C-
ANCA in a patient suspected of having
Wegener’s Granulomatosus is:
A. Topoisomerase
B. Histidine tRNA synthetase
C. Smith (Sm)
D. Proteinase-3
E. Myeloperoxidase
C is the 3rd
letter of the alphabet:
Pr-3 C-ANCA
49. Granulomatous Polyangiitis (GPA) …
formerly Wegener’s
• Classical triad URT + LRT + renal
• Necrotizing vasculitis that affects the small
vessels of the respiratory tract and renal
system: PULMONARY-RENAL SYNDROME
• Age ~ 40s: M > F 2:1
51. Granulomatous Polyangiitis (GPA) : Respiratory
Involvement
• Sinusitis
– Nasal septal ulceration
• Pneumonitis
– few symptoms until late
– usually no mediastinal
lymphadenopathy
– nodules that can cavitate
54. Granulomatous Polyangiitis (GPA) : ANCA
• AntiNeutrophil Cytoplasmic Antibody
– C (cytoplasmic staining) ANCA
– Proteinase 3 (C is the 3rd
letter)
• Pulmonary-renal disease
– sensitivity of 95%
– specificity of 95%
• Limited disease…
– lower sensitivity and specificity
55.
56. Granulomatous Polyangiitis (GPA): Tissue Biopsy
• Yield of biopsy
– Lung
• Open – highest yield
• Bronchoscopy - lower yield
– Sinus - 40% yield
– Renal
• Vasculitis rarely seen
• Focal proliferative GN is the typical finding
57. Granulomatous Polyangiitis (GPA) : Rx
• Prior to cyclophosphamide, 80-90% mortality
• With cyclophosphamide, 5-10% mortality
• Concern about long-term toxicity of PO
cyclophosphamide (bladder especially)
• IV CYTOXAN no significant bladder risk due to less
cumulative dose
• Rituximab: very effective for induction &
maintenance
• Azathioprine for maintenance
58. Microscopic Polyangiitis (MPA)
• Systemic vasculitis with predominant small
vessel involvement
• Separate disease from PAN (Initially thought to be a
variant of PAN)
• Usually RPGN and sometimes with
pulmonary hemorrhage
• More common than PAN (both are rare)
70. Polyarteritis Nodosa
• Necrotizing vasculitis of medium & small arteries
• Age ~ 40s; M > F
• Constitutional symptoms are common
– fever 50%
– weight loss 50%
• Vasculitis can be variable in distribution making
diagnosis difficult
71. Polyarteritis Nodosa
ACR Criteria (3 of 10)
• Wt loss > 4 kg
• Livedo reticularis
• Testicular pain
• Myalgias, weakness or leg
tenderness
• Mononeuropathy or
polyneuropathy
• Diastolic BP > 90
• ⇑ BUN or Creatinine
• Hepatitis B virus
• Arteriographic abnormality
• Biopsy of small or medium
artery containing PAN
Arthritis Rheum. 1990;33:1088
Note White blood cells in the media and adventitia of the vasculitic artery
Palpable purpura is caused by rbc extravasation from small vessels that have been occluded by immune complexes. They are heavy and tend to occur in the most gravity-dependent area of the body.
All of us develop this “lacy” vascular pattern when we are cold. However livedo reticularis is caused by relative ischemia of the capillary beds. Vasculitis is one of the causes of livedo.
Splinter hemorrhages can be found in the distal nail bed and/or in the periungual area.
Note that the nerve tissue is seen at the bottom of the picture. The vessel infiltration with white blood cells occurs in the vasa nervorum.
Cellular and Fibrous Crescent Formation in glomerulonephritis. Testicular pain is uncommon in systemic vasculitis, but when it occurs, it is relatively specific for polyarteritis nodosum (PAN).
Scleritis and iritis (uveitis) present with a red eye, ocular pain, photophobia and decreased vision. Note the “ciliary flush” (erythema adjacent to the iris) in iritis. You can see exudates on the fundoscopic view of retinal vasculitis. All can be clinical manifestations of vasculitis.
All of these laboratory findings are nonspecific features of the intense inflammatory response seen in vasculitis.
The temporal artery in this picture would be expected to have decreased pulsations, to be thickened and painful upon palpation. It is unusual to see the temporal artery abnormalities in recent times.
Necrosis of the intima and media with disruption of the internal elastic lamina.
A. Topoisomerase (SCL-70) - Scleroderma
B. Histidine tRNA synthetase (Jo-1) – ILD/PM
C. Smith (Sm) - SLE
D. Proteinase-3 – Wegener’s Granulomatosis
E. Myeloperoxidase
(MPO) MPA
Note again the fibrocellular cresent inside of Bowman’s capsule.
The picture shows neutrophils with fluorescent staining of the entire cytoplasm.
RPGN = Rapidly Progressive Glomerulonephritis (another term that describes the aggressive glomerulonephritis seen in association with vasculitis – it is not specific for MPA.
Neutrophils with fluorescent staining of the cytoplasm in a perinuclear distribution.
In PAN, note glomerulonephritis is less common than hypertension, reflecting the tendency for this disease to affect larger vessels.